Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,376 Results (Page 57 of 119)
- Relevance
  Sort by

Europe Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
93 Pages
Europe

From

€1328EUR$1,500USD£1,148GBP

LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
93 Pages
Africa, Middle East

From

€1328EUR$1,500USD£1,148GBP

North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
83 Pages
North America

From

€1328EUR$1,500USD£1,148GBP

Dermatological Drugs - Global Strategic Business Report

 Report
May 2026
422 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
January 2023
1452 Pages
Global

From

€4428EUR$5,000USD£3,826GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Skin Rash Treatment Market - Global Strategic Business Report

 Report
May 2026
384 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Dermatology Drugs - Global Strategic Business Report

 Report
May 2026
372 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Pruritus Therapeutics - Global Strategic Business Report

 Report
May 2026
192 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Keloid Treatment Market - Global Strategic Business Report

 Report
May 2026
280 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

B-cell Lymphoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
450 Pages
Global

From

€4428EUR$5,000USD£3,826GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
183 Pages
Global

From

€3985EUR$4,500USD£3,444GBP

Analgesics - Global Strategic Business Report

 Report
May 2026
482 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Autoinjectors Market Industry Trends and Global Forecasts to 2035: Distribution by Usability, Route of Administration, Type of Molecule Delivered, Volume of Container, Type of Actuation Mechanism, End-user, Target Indication and Key Geographical Regions

 Report
September 2024
593 Pages
Global

From

€4250EUR$4,799USD£3,672GBP

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3099EUR$3,500USD£2,678GBP

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
67 Pages
Global

From

€3099EUR$3,500USD£2,678GBP

Follicular Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
150 Pages
Global

From

€2214EUR$2,500USD£1,913GBP

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2657EUR$3,000USD£2,296GBP

CAR-T Cell Therapy Market - Market Size, Forecasts, Trials, and Trends, 2025

 Report
December 2024
332 Pages
Global

From

€3717EUR$4,197USD£3,212GBP

Pancreatic Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
204 Pages
Global

From

€4206EUR$4,750USD£3,635GBP

Idiopathic Pulmonary Fibrosis - Global Strategic Business Report

 Report
May 2026
181 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

2,376 Results (Page 57 of 119)
- 1
- 55
- 56
- 57
- 58
- 59

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.